课题基金 / 基金详情

Physiological roles of Ewings Sarcoma gene product EWS

Physiological roles of Ewings Sarcoma gene product EWS
尤文氏肉瘤基因产物 EWS 的生理作用
批准号:
8349846
负责人:
Sean Lee
金额:
$45.06万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Sean Lee的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ewing's sarcoma gene (EWS) belongs to a family of TET proteins, which include TLS/FUS and TAFII15. These proteins encode RNA binding domain at the C-terminal end and a large repeats of SYGOO motif at their N-terminus. Based on the physical interactions with RNA polymerase II and splicing factors, TET proteins are thought to play roles in basic transcription and splicing. However, in vivo role of EWS and other TET proteins has not been demonstrated. Thus, the goal of this project is to understand the in vivo function of EWS and to relate that function in the context of the chromosomal translocation found in Ewing's sarcoma and other EWS-fusion sarcomas. Aim 1. We will generate EWS knockout mouse by gene targeting approach. We have already generated the knockout mouse derived from the targeted mouse ES cells. Aim 2. To characterize the defects caused by EWS deficiency in the knockout mouse. Aim 3. To characterize the EWS deficiency at the cellular level to identify the mechanisms by which EWS functions. The knowledge gained from this study will help to better understand about EWS and other TET proteins in general. This will further elucidate how EWS or TLS related fusion products will lead to tumorigenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mouse models of Desmoplastic Small Round Cell Tumor and Ewings sarcoma
Characterization Of Wilms Tumor Suppressor Gene Product Wt1
Mouse models of Desmoplastic Small Round Cell Tumor and Ewings sarcoma
Physiological roles of Ewings Sarcoma gene product EWS
国内基金
海外基金
分化肌细胞脱细胞ECM-cells sheet 3D 支架构建及其促进容积性肌组织缺损再 生修复应用及机制研究
CAFs-TAMs-tumor cells调控在HRHPV感染致癌中的作用机制研究及AI可追溯预测模型建立
  • 批准号:
    82072862
  • 项目类别:
    面上项目
  • 资助金额:
    56.0万元
  • 批准年份:
    2020
  • 负责人:
    徐云升
  • 依托单位:
S100A8/A9--Myeloid cells特异性可溶性表氧化物水解酶(sEH)基因敲除改善胰岛素抵抗的新靶点
  • 批准号:
    82070825
  • 项目类别:
    面上项目
  • 资助金额:
    53.0万元
  • 批准年份:
    2020
  • 负责人:
    徐西振
  • 依托单位:
Leader cells通过CCL5调控糖酵解及基质硬度促进结直肠癌集体侵袭的 作用机制
  • 批准号:
    81903002
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.5万元
  • 批准年份:
    2019
  • 负责人:
    王斐斐
  • 依托单位: